List Includes Medicines For Bacterial Infection, Acidity, Vomiting, Vitamin Deficiencies

Pune: The Food and Drugs Administration (FDA) has prohibited the distribution and sale of particular batches of drugs meant to treat bacterial infection, acidity, stomach ulcers, vomiting and vitamin deficiencies, due to their substandard quality.

"These are batches of 13 medicines whose distribution and sale has been prohibited by the Food and Drug Administration (FDA), Maharashtra, due to substandard quality and for violating various provisions of the Drug and Cosmetic Act 1940 and rules 1945," said B R Masal, joint commissioner, FDA, Pune.

Most of the manufacturers of substandard drugs found by the FDA are from Gujarat, Madhya Pradesh, Himachal Pradesh, Uttaranchal and Punjab.

"Most manufacturers who faced action are from outside Maharashtra. The two from the state are in Thane and Kurla," said Masal. We have asked the FDA of the respective states to take appropriate action against them," said Masal. He said the two drug manufacturers in Maharashtra have been asked to withdraw the particular batches of medicine found unfit and substandard from the market.

"The FDA authorities of other states have also been told to ask the erring manufacturers in their region to withdraw the substandard drugs. Government hospitals, medical colleges attached to hospitals and doctors’ organisations have also been told the names and batches of the drugs, which have been banned for sale in Maharashtra."

The chemists and druggists associations are now expected to warn their members and retailers against selling the particular batches, Masal said.

TOI has a copy of the list of drugs that the Drug Control Laboratory has reported to be of substandard quality. Samples were taken for analysis from different destinations in Maharashtra in January and declared not of standard.

"We advise people against using particular batches of these medicines," said Masal.

Drugs prohibited for sale by the FDA
Cefbil 100 (batch no:D–3305), Cefbil 50 (batch no:D–3407); Pantoprazole and Domperidone tablets/Pentwok D (batch no: WDM1114); Pentotec–D Pantoprazole and Domperidone tablets (batch no: DG0345); Hemnir Iron tonic (batch number:NLH–106); Novaplex Syrup (batch number:NPIII–017); Bolizyme Syrup (batch number:SML–147); Razogard (Rabeprazole sodium tablets with sodium BI) (batch number: RBZ1G1); Nuzyme Liquid (batch number: 215); Phenidex Suspension (batch number:2019); multivitamin infusion (batch number: I–061), Mamfiz Liquid (batch number MNL–227); Pantoprazole and Domperidone tablets Pansa–D (batch number: ZVA11007)